Single-Cell Genome Sequencing Market

Single-Cell Genome Sequencing Market accounted for US$ 1.47 billion in 2020 and is estimated to be US$ 4.72 billion by 2030 and is anticipated to register a CAGR of 13.1%. Single cell sequencing inspects the arrangement data from singular cells with streamlined cutting edge sequencing (NGS) innovations, giving a higher goal of cell contrasts and a superior comprehension of the capacity of an individual cell with regards to its microenvironment. For instance, in malignancy, sequencing the DNA of individual cells can give data about transformations conveyed by little populaces of cells. Being developed, sequencing the RNAs communicated by singular cells can give knowledge into the presence and conduct of various cell types. In microbial frameworks, a populace of similar animal categories can give off an impression of being hereditarily clonal, yet single-cell sequencing of RNA or epigenetic adjustments can uncover cell-to-cell changeability that might assist populaces with adjusting make due in changing conditions.

The report “Global Single-Cell Genome Sequencing Market, By Type (Reagents and Instruments), By Technology (NGS, PCR, qPCR, MDA, and Microarray), By Application (Circulating Cells, Genomic Variation, Cell Differentiation, Subpopulation Characterization, and Others), By End-User (Forensic Labs, Cell banks and IVF centers, Academic & Research Laboratories, Biotechnology & biopharmaceutical companies, and Hospitals and diagnostic laboratories) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

• In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been produced for solidified designated DNA and RNA improvement and investigations. These boards save time and save tests that are of restricted accessibility.
• In July 2019, QIAGEN collaborated with Illumina with the plan to widen the accessibility and utilization of NGS-situated in vitro symptomatic (IVD) units.
• In June 2019, Beckman Coulter obtained Cytobank, Inc. (US) to coordinate Cytobank's product into Beckman Coulter's item portfolio to give inventive answers for clients.

Analyst View:

Dynamic support and commitment of market players toward item upgradation are assuming a significant part in the development of the market. Expanding number of joint efforts and key unions between organizations are encouraging the advancement of a synergistic portfolio in the framework. Besides, rise of cutting edge sequencing (NGS) has helped the market acquire huge footing in the course of recent years. Prior, single-cell genome sequencing market was overwhelmed by PCR and microarray innovations. In any case, qPCR and NGS are progressively arising as the favored advances.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/78

Key Market Insights from the report:

The global Single-Cell Genome Sequencing market accounted for US$ 1.47 billion in 2020 and is estimated to be US$ 4.72 billion by 2030 and is anticipated to register a CAGR of 13.1%. The global single-cell genome sequencing market has been segmented on the basis of type, technology, application, end-user, and region.

• By Type, the Global Single-Cell Genome Sequencing Market is segmented into Reagents and Instruments.
• By Technology, the Global Single-Cell Genome Sequencing Market is segmented into NGS, PCR, qPCR, MDA, and Microarray.
• By Application, the Global Single-Cell Genome Sequencing Market is segmented into Circulating Cells, Genomic Variation, Cell Differentiation, Subpopulation Characterization, and Others.
• By End-User, the Global Single-Cell Genome Sequencing Market is segmented into Forensic Labs, Cell banks and IVF centers, Academic & Research Laboratories, Biotechnology & biopharmaceutical companies, and Hospitals and diagnostic laboratories.
• By region, the Global Single-Cell Genome Sequencing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Competitive Landscape:

Key players operating in the global market of single-cell genome sequencing include ThermoFisher Scientific, Inc., Illumina, Bio-Rad, BD, Pacific Biosciences of California, Inc., QIAGEN, 10X Genomics, Inc., BGI, Novogene Co. Ltd., NuGEN Technologies, Inc., Takara Bio, Inc., F Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, Fludigim, and Agilent Technologies Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Other Related Reports:-

https://chaitanya21blogs.blogspot.com/2022/10/web-conferencing-market-is-estimated-to.html

https://chaitanya21blogs.blogspot.com/2022/10/human-capital-management-software.html

https://chaitanyahcblogs.blogspot.com/2022/10/veterinary-imaging-market-is-estimated.html

Article source: https://article-realm.com/article/Internet-Business/Auctions/30104-Single-Cell-Genome-Sequencing-Market.html